Stockreport

Treadwell Announces Ocifisertib, a First-in-Class PLK4 Inhibitor, has Received Orphan Designation from U.S. FDA for the Treatment of Acute Myeloid Leukemia [Yahoo! Finance]

TRACON Pharmaceuticals, Inc.  (TCON) 
Last tracon pharmaceuticals, inc. earnings: 2/27 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: traconpharma.com
PDF TORONTO & SAN FRANCISCO, February 20, 2024 BUSINESS WIRE )--Treadwell Therapeutics, a privately held clinical-stage biotechnology company pioneering and advancing novel [Read more]